Essex Investment Management CO LLC Clovis Oncology, Inc. Transaction History

Essex Investment Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$11.63 - $32.67 $418,633 - $1.18 Million	-35,996 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$29.37 - $49.48 $605,403 - $1.02 Million	20,613 Added 134.0%	35,996 $1.06 Million
Q2 2018 Jul 17, 2018	SELL	$42.06 - $62.4 $275,030 - $408,033	-6,539 Reduced 29.83%	15,383 $699,000
Q1 2018 Apr 26, 2018	BUY	$50.12 - $67.72 $1.1 Million - $1.48 Million	21,922 New	21,922 $1.16 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.